About Stanford LPCH Vaccine Program
Clinical Trials at Stanford LPCH Vaccine Program
During the past decade, Stanford LPCH Vaccine Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford LPCH Vaccine Program"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Stanford LPCH Vaccine Program
According to Clinical.Site data, the most researched conditions in "Stanford LPCH Vaccine Program" are
"Influenza" (3 trials), "Healthy Adults" (1 trials), "Hepatitis A" (1 trials) and "Typhoid" (1 trials). Many other conditions were trialed in "Stanford LPCH Vaccine Program" in a lesser frequency.
Clinical Trials Intervention Types at Stanford LPCH Vaccine Program
Most popular intervention types in "Stanford LPCH Vaccine Program" are "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "2011-2012 FluMist®" (1 trials), "FluMist® 2009-2010 Formula" (1 trials), "Fluad" (1 trials), "Fluzone High Dose" (1 trials) and "Fluzone® (IM)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford LPCH Vaccine Program
The vast majority of trials in "Stanford LPCH Vaccine Program" are
3 trials for "All" genders.
Clinical Trials Status at Stanford LPCH Vaccine Program
Currently, there are NaN active trials in "Stanford LPCH Vaccine Program".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Stanford LPCH Vaccine Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford LPCH Vaccine Program, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".